WORLAND STEPHEN T
Insider CIK 1283307 · TCON Director · GNMK Director · EFTR President and Chief Executive, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2024-05-15 | 2024-05-17 | 1,806 | $1.68 | $3.0K | 12,494 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-02-19 | 2024-02-21 | 80,000 | — | $0 | 80,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2023-11-15 | 2023-11-16 | 5,979 | $0.50 | $3.0K | 267,204 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | M Exercise deriv | 2023-08-11 | 2023-08-14 | 33,799 | — | $0 | 0 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | M Exercise | 2023-08-11 | 2023-08-14 | 33,799 | $0.52 | $17.6K | 261,225 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2023-05-15 | 2023-05-16 | 6,401 | $0.46 | $2.9K | 227,426 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2023-04-19 | 2023-04-21 | 18,000 | — | $0 | 18,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-01-17 | 2023-01-19 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2022-11-15 | 2022-11-16 | 6,047 | $0.47 | $2.8K | 221,025 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-06-20 | 2022-06-22 | 520,674 | — | $0 | 520,674 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2022-06-14 | 2022-06-16 | 15,750 | — | $0 | 15,750 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-06-07 | 2022-06-09 | 20,000 | $1.37 | $27.4K | 214,978 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2022-05-13 | 2022-05-17 | 1,837 | $1.53 | $2.8K | 194,978 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-01-20 | 2022-01-24 | 520,674 | — | $0 | 520,674 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 144,856 | — | $0 | 144,856 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 619,018 | — | $0 | 619,018 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 33,799 | — | $0 | 33,799 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 289,712 | — | $0 | 289,712 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 75,472 | — | $0 | 75,472 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 220,639 | — | $0 | 220,639 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 217,284 | — | $0 | 217,284 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2021-08-25 | 2021-08-27 | 193,141 | — | $0 | 755,480 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2021-08-25 | 2021-08-27 | 50,000 | $10.00 | $500.0K | 562,339 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2021-08-25 | 2021-08-27 | 512,339 | — | $0 | 512,339 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2021-06-10 | 2021-06-24 | 10,500 | — | $0 | 10,500 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2020-06-10 | 2020-06-16 | 4,500 | — | $0 | 4,500 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2019-06-13 | 2019-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2018-06-13 | 2018-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2017-06-15 | 2017-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award | 2016-06-01 | 2016-06-02 | 7,500 | — | $0 | 7,500 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2015-07-23 | 2015-07-24 | 6,103 | — | $0 | 6,103 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2015-07-23 | 2015-07-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2015-02-25 | 2015-02-27 | 18,897 | — | $0 | 18,897 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2014-05-29 | 2014-06-02 | 5,677 | — | $0 | 20,599 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2013-05-22 | 2013-05-23 | 14,922 | — | $0 | 14,922 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award deriv | 2012-06-13 | 2012-06-15 | 25,000 | — | $0 | 25,000 | SEC↗ |